Bilateral choroidal tuberculoma in a patient of miliary tuberculosis.

IF 2 Q1 OPHTHALMOLOGY
Tanya Jain, Sachit Mahajan, Aishwaraya Kanagaraj, Vivek Jha
{"title":"Bilateral choroidal tuberculoma in a patient of miliary tuberculosis.","authors":"Tanya Jain, Sachit Mahajan, Aishwaraya Kanagaraj, Vivek Jha","doi":"10.1186/s12348-025-00509-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Choroidal granuloma is one of the common manifestations of ocular tuberculosis. Tubercles indicate hematogenous dissemination of the disease. Tubercular granulomas respond to Anti-Tubercular Treatment (ATT) and systemic corticosteroids. However, in some patients with large granulomas involving macula, adjunct treatment with intravitreal anti-VEGF may be required for prompt management of the granuloma.</p><p><strong>Findings: </strong>We report a case of bilateral Tubercular granuloma in a patient with miliary Tuberculosis (TB). The patient was an immunocompetent young female with miliary tuberculosis. Mantoux was positive. HRCT chest suggested miliary TB. The patient was already on ATT. Clinical examination showed multiple TB granulomas in both eyes, with a large granuloma involving the fovea in the left eye. She underwent intravitreal injection of the anti-VEGF drug bevacizumab (1.25 mg/0.05 mL) (off-label use) with moxifloxacin (500 µg/0.1 mL) (off-label use) in the left eye. She was continued on ATT and was started on oral steroids. After seven weekly intravitreal injections in the left eye at the second-month follow-up, lesions were consolidated and scarred. Optical coherence tomography showed a decrease in the size of the choroidal bump.</p><p><strong>Conclusion: </strong>Weekly administration of intravitreal Anti-Vascular endothelial growth factor(VEGF) and moxifloxacin, along with ATT and oral corticosteroids, has controlled inflammation and has caused consolidation and scarring of TB granulomas in a patient with miliary TB.</p>","PeriodicalId":16600,"journal":{"name":"Journal of Ophthalmic Inflammation and Infection","volume":"15 1","pages":"77"},"PeriodicalIF":2.0000,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12552196/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ophthalmic Inflammation and Infection","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s12348-025-00509-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Choroidal granuloma is one of the common manifestations of ocular tuberculosis. Tubercles indicate hematogenous dissemination of the disease. Tubercular granulomas respond to Anti-Tubercular Treatment (ATT) and systemic corticosteroids. However, in some patients with large granulomas involving macula, adjunct treatment with intravitreal anti-VEGF may be required for prompt management of the granuloma.

Findings: We report a case of bilateral Tubercular granuloma in a patient with miliary Tuberculosis (TB). The patient was an immunocompetent young female with miliary tuberculosis. Mantoux was positive. HRCT chest suggested miliary TB. The patient was already on ATT. Clinical examination showed multiple TB granulomas in both eyes, with a large granuloma involving the fovea in the left eye. She underwent intravitreal injection of the anti-VEGF drug bevacizumab (1.25 mg/0.05 mL) (off-label use) with moxifloxacin (500 µg/0.1 mL) (off-label use) in the left eye. She was continued on ATT and was started on oral steroids. After seven weekly intravitreal injections in the left eye at the second-month follow-up, lesions were consolidated and scarred. Optical coherence tomography showed a decrease in the size of the choroidal bump.

Conclusion: Weekly administration of intravitreal Anti-Vascular endothelial growth factor(VEGF) and moxifloxacin, along with ATT and oral corticosteroids, has controlled inflammation and has caused consolidation and scarring of TB granulomas in a patient with miliary TB.

Abstract Image

Abstract Image

Abstract Image

1例军人结核患者的双侧脉络膜结核瘤。
背景:脉络膜肉芽肿是眼结核的常见表现之一。结核表明疾病是通过血液传播的。结核性肉芽肿对抗结核治疗(ATT)和全身皮质类固醇有反应。然而,在一些涉及黄斑的大肉芽肿患者中,可能需要玻璃体内抗vegf辅助治疗以及时处理肉芽肿。结果:我们报告一例双侧结核性肉芽肿患者与军人结核(TB)。患者是一名具有免疫功能的年轻女性,患有军旅性肺结核。曼图克斯是积极的。胸部HRCT提示军旅性结核。患者已行ATT检查。临床检查显示双眼多发结核肉芽肿,左眼大肉芽肿累及中央窝。左眼玻璃体内注射抗vegf药物贝伐单抗(1.25 mg/0.05 mL)(超说明书使用)和莫西沙星(500µg/0.1 mL)(超说明书使用)。她继续服用ATT,并开始口服类固醇。在第二个月的随访中,在左眼进行每周7次的玻璃体内注射后,病变得到巩固和疤痕。光学相干断层扫描显示脉络膜肿块大小减小。结论:每周给予玻璃体内抗血管内皮生长因子(VEGF)和莫西沙星,以及ATT和口服皮质类固醇,可以控制炎症,并导致军人结核病患者结核肉芽肿巩固和瘢痕形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
3.40%
发文量
39
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书